Jeffrey Scott Sherman net worth and biography

Jeffrey Sherman Biography and Net Worth

CFO of NeoGenomics

Jeff has over 32 years of finance experience in the healthcare services industry, having gained a well-rounded background from serving in finance roles at public companies of different sizes and at different growth stages in their lifecycle. While he has most recently served as Chief Financial Officer of Privia Health Group, Inc., a national physician enablement company, Jeff has also served as the Chief Financial Officer at three other organizations: HMS, a technology analytics and engagement solutions provider for government and commercial healthcare payers; AccentCare, a multi-state community-based healthcare delivery organization; and LIFEPOINT Health, a non-urban private hospital company operating 72 hospitals. Jeff also held various finance roles of increasing scope and responsibility at Tenet Healthcare Corporation.

Jeff received a B.A. in Finance/Accounting from the University of Colorado, Boulder, and an MBA from the University of Southern California.

When not working, he enjoys running, biking outside, hiking, and skiing with his family.

What is Jeffrey Scott Sherman's net worth?: The estimated net worth of Jeffrey Scott Sherman is at least $1.93 million as of May 2nd, 2025. Sherman owns 158,494 shares of NeoGenomics stock worth more than $1,928,872 as of December 5th. This net worth estimate does not reflect any other investments that Sherman may own. Additionally, Sherman receives an annual salary of $1,170,000.00 as CFO at NeoGenomics. Learn More about Jeffrey Scott Sherman's net worth.
How old is Jeffrey Scott Sherman?: Sherman is currently 58 years old. There are 6 older executives and no younger executives at NeoGenomics. The oldest executive at NeoGenomics is Mr. Christopher Michael Smith BSc, CEO & Director, who is 61 years old. Learn More on Jeffrey Scott Sherman's age.
What is Jeffrey Scott Sherman's salary?: As the CFO of NeoGenomics, Inc., Sherman earns $1,170,000.00 per year. There are 3 executives that earn more than Sherman. The highest earning executive at NeoGenomics is Mr. Christopher Michael Smith BSc, CEO & Director, who commands a salary of $2,860,000.00 per year. Learn More on Jeffrey Scott Sherman's salary.
How do I contact Jeffrey Scott Sherman?: The corporate mailing address for Sherman and other NeoGenomics executives is 12701 COMMONWEALTH DRIVE SUITE 9, FORT MYERS FL, 33913. NeoGenomics can also be reached via phone at (239) 768-0600 and via email at [email protected]. Learn More on Jeffrey Scott Sherman's contact information.
Has Jeffrey Scott Sherman been buying or selling shares of NeoGenomics?: Jeffrey Scott Sherman has not been actively trading shares of NeoGenomics in the last ninety days. Most recently, on Friday, May 2nd, Jeffrey Scott Sherman bought 20,000 shares of NeoGenomics stock. The stock was acquired at an average cost of $7.51 per share, with a total value of $150,200.00. Following the completion of the transaction, the chief financial officer now directly owns 158,494 shares of the company's stock, valued at $1,190,289.94. Learn More on Jeffrey Scott Sherman's trading history.
Who are NeoGenomics' active insiders?: NeoGenomics' insider roster includes (), Douglas Brown (Insider), George Cardoza (Insider), Bruce Crowther (Director), Stephen Kanovsky (Director), Michael Kelly (Director), Mark Mallon (CEO), Kathryn McKenzie (CFO), Alicia Olivo (Executive Vice President, General Counsel & Business Development), David Perez (Director), Jeffrey Sherman (CFO), Robert Shovlin (Insider), Warren Stone (President and Chief Operating Officer), Lynn Tetrault (Director), and Anthony Zook (CEO). Learn More on NeoGenomics' active insiders.
Are insiders buying or selling shares of NeoGenomics?: During the last year, NeoGenomics insiders bought shares 7 times. They purchased a total of 70,600 shares worth more than $550,438.00. During the last year, insiders at the medical research company sold shares 1 times. They sold a total of 20,916 shares worth more than $250,992.00. The most recent insider tranaction occured on November, 25th when EVP Alicia C Olivo sold 20,916 shares worth more than $250,992.00. Insiders at NeoGenomics own 2.4% of the company. Learn More about insider trades at NeoGenomics.
Information on this page was last updated on 11/25/2025.

Jeffrey Scott Sherman Insider Trading History at NeoGenomics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/2/2025	Buy	20,000	$7.51	$150,200.00	158,494

Jeffrey Scott Sherman Buying and Selling Activity at NeoGenomics

NeoGenomics Company Overview

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

Today's Range

Now: $12.17

$11.94

$12.26

50 Day Range

MA: $10.21

$7.72

$12.34

2 Week Range

Now: $12.17

$4.72

$19.11

Volume

1,233,955 shs

Average Volume

1,981,554 shs

Market Capitalization

$1.57 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.6

Jeffrey Sherman Biography and Net Worth

What is Jeffrey Scott Sherman's net worth?

How old is Jeffrey Scott Sherman?

What is Jeffrey Scott Sherman's salary?

How do I contact Jeffrey Scott Sherman?

Has Jeffrey Scott Sherman been buying or selling shares of NeoGenomics?

Who are NeoGenomics' active insiders?

Are insiders buying or selling shares of NeoGenomics?